Scholars Central

Conference abstractPublished 14 Dec 2017

The induction of antigen-specific and protective cellular immune responses against Mycobacterium tuberculosis-specific proteins

Authors: Hussain A Safar

Kuwait University, Kuwait

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Tuberculosis and asthma are worldwide public health problems of major concern. Effective vaccines are needed to control these diseases globally. In both diseases, the protective immunity is mediated by T-helper (Th)1 cytokines (primarily interferon-gamma, IFN-Ã?£), whereas, Th2 (IL-5), Th17 (IL-17A) and T regulatory (IL-10) cytokines are pathologic. The aim of this study was to obtain recombinant Mycobacterium tuberculosis-specific proteins and study the induction of protective (Th1) and pathologic (Th2, TH17 and Treg) immune responses by immunizing mice. The genes encoding Mycobacterium tuberculosis-specific proteins ESXA, ESXB, ESXO, ESXV and PE35 were cloned into pGES-TH1 vector and expressed in Escherichia coli. The recombinant proteins were purified to homogeneity using affinity chromatography. Female BALB/c mice were immunized and boosted with purified recombinant proteins emulsified in incomplete Freund’s adjuvant. Two weeks after the last booster, mice were euthanized and spleen cells were cultured in vitro in the presence of Concanavalin A and mixture of synthetic peptides covering the sequence of immunizing proteins. The culture supernatants were collected after appropriate time intervals and the concentrations of secreted INF-Ã?£, IL-5, IL-10 and IL-17A were quantified using enzymelinked immunosorbent assay. All the genes were successfully expressed in E. coli and the recombinant proteins were purified to homogeneity. The experiments with spleen cells from the immunized mice showed that ESXO, ESXV and PE35 stimulated only Th1 responses. The induction of protective Th1 responses in mice immunized with PE35, ESXO and ESXV proteins suggests their potential as new candidate vaccines against tuberculosis and asthma.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Cellular Immunology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Hussain A Safar”